ANIXA BIOSCIENCES, INC. Stock Issued During Period, Shares, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ANIXA BIOSCIENCES, INC. stock issued during period, shares, new issues for the quarter ending 2025-07-31 was 596.97K shares.
- ANIXA BIOSCIENCES, INC. stock issued during period, shares, new issues for the quarter ending 2024-01-31 was 555.82K shares.
- ANIXA BIOSCIENCES, INC. stock issued during period, shares, new issues for the quarter ending 2019-07-31 was -147.78K shares.
- ANIXA BIOSCIENCES, INC. stock issued during period, shares, new issues for the quarter ending 2019-04-30 was -509.43K shares.
| Period end | Stock Issued During Period, Shares, New Issues 3 month | Stock Issued During Period, Shares, New Issues 12 month |
|---|---|---|
| 2025-07-31 | 596.97K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-09-10 | |
| 2024-01-31 | 555.82K shares 10-Q · filed 2024-03-12 | |
| 2019-07-31 | -147.78K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-09-06 | |
| 2019-04-30 | -509.43K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-06-12 | |
| 2019-01-31 | 924.51K shares 10-Q · filed 2019-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |